164 related articles for article (PubMed ID: 8311129)
1. Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease.
Pennathur A; Tran A; Cioppi M; Fayad J; Sieren GL; Little AG
Am J Surg; 1994 Jan; 167(1):169-72; discussion 172-3. PubMed ID: 8311129
[TBL] [Abstract][Full Text] [Related]
2. Erythromycin, motilin, and the esophagus.
Pennathur A; Cioppi M; Fayad JB; Little AG
Surgery; 1993 Aug; 114(2):295-8; discussion 298-9. PubMed ID: 8342132
[TBL] [Abstract][Full Text] [Related]
3. Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves.
Chaussade S; Michopoulos S; Sogni P; Guerre J; Couturier D
Dig Dis Sci; 1994 Feb; 39(2):381-4. PubMed ID: 8313822
[TBL] [Abstract][Full Text] [Related]
4. The effect of intravenous erythromycin on esophageal motility in healthy subjects.
Tzovaras G; Xynos E; Chrysos E; Mantides A; Vassilakis JS
Am J Surg; 1996 Mar; 171(3):316-9. PubMed ID: 8615464
[TBL] [Abstract][Full Text] [Related]
5. Effects of LY267108, an erythromycin analogue derivative, on lower esophageal sphincter function in the cat.
Greenwood B; Dieckman D; Kirst HA; Gidda JS
Gastroenterology; 1994 Mar; 106(3):624-8. PubMed ID: 8119532
[TBL] [Abstract][Full Text] [Related]
6. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
Koutsoumbi P; Epanomeritakis E; Tsiaoussis J; Athanasakis H; Chrysos E; Zoras O; Vassilakis JS; Xynos E
Am J Gastroenterol; 2000 Dec; 95(12):3388-92. PubMed ID: 11151866
[TBL] [Abstract][Full Text] [Related]
7. Esophageal Infusion of Menthol Does Not Affect Esophageal Motility in Patients with Gastroesophageal Reflux Disease.
Bánovčin P; Lipták P; Vážanová D; Hoferica J; Tatár M; Ďuriček M
Dysphagia; 2024 Jun; 39(3):369-375. PubMed ID: 37728794
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of routine esophageal high-resolution manometry for gastro-esophageal reflux disease.
van Hoeij FB; Smout AJ; Bredenoord AJ
Neurogastroenterol Motil; 2015 Jul; 27(7):963-70. PubMed ID: 25930019
[TBL] [Abstract][Full Text] [Related]
9. Motilin: a mechanism incorporating the opossum lower esophageal sphincter into the migrating motor complex.
Holloway RH; Blank E; Takahashi I; Dodds WJ; Layman RD
Gastroenterology; 1985 Sep; 89(3):507-15. PubMed ID: 4018497
[TBL] [Abstract][Full Text] [Related]
10. Effect of atilmotin, a motilin receptor agonist, on esophageal, lower esophageal sphincter, and gastric pressures.
Korimilli A; Parkman HP
Dig Dis Sci; 2010 Feb; 55(2):300-6. PubMed ID: 19997977
[TBL] [Abstract][Full Text] [Related]
11. Effect of amino acids on lower esophageal sphincter characteristics and gastroesophageal reflux in humans.
Gielkens HA; Lamers CB; Masclee AA
Dig Dis Sci; 1998 Apr; 43(4):840-6. PubMed ID: 9558042
[TBL] [Abstract][Full Text] [Related]
12. Manometric Changes to the Lower Esophageal Sphincter After Magnetic Sphincter Augmentation in Patients With Chronic Gastroesophageal Reflux Disease.
Warren HF; Louie BE; Farivar AS; Wilshire C; Aye RW
Ann Surg; 2017 Jul; 266(1):99-104. PubMed ID: 27464617
[TBL] [Abstract][Full Text] [Related]
13. Motilin effects on gastrointestinal motility and lower esophageal sphincter (LES) pressure in dogs.
Jennewein HM; Bauer R; Hummelt H; Lepsin G; Siewert R; Waldeck F
Scand J Gastroenterol Suppl; 1976; 39():63-5. PubMed ID: 1069365
[TBL] [Abstract][Full Text] [Related]
14. Lower esophageal sphincter pressure and serum motilin levels.
Eckardt V; Grace ND
Am J Dig Dis; 1976 Dec; 21(12):1008-11. PubMed ID: 13651
[TBL] [Abstract][Full Text] [Related]
15. Early effects of bethanechol on the esophageal motor function of infants with gastroesophageal reflux.
Sondheimer JM; Arnold GL
J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):47-51. PubMed ID: 2868087
[TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease is associated with enteric hormone abnormalities.
Perdikis G; Wilson P; Hinder RA; Redmond EJ; Wetscher GJ; Saeki S; Adrian TE
Am J Surg; 1994 Jan; 167(1):186-91; discussion 191-2. PubMed ID: 8311131
[TBL] [Abstract][Full Text] [Related]
17. [Roles of diaphragmatic crural barrier and esophageal body clearance in patients with gastroesophageal reflux disease].
Sun XH; Ke MY; Wang ZF; Fang XC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):289-93. PubMed ID: 12905637
[TBL] [Abstract][Full Text] [Related]
18. The motilin receptor agonist erythromycin stimulates hunger and food intake through a cholinergic pathway.
Deloose E; Vos R; Janssen P; Van den Bergh O; Van Oudenhove L; Depoortere I; Tack J
Am J Clin Nutr; 2016 Mar; 103(3):730-7. PubMed ID: 26817505
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium valproate on esophageal motility in healthy subjects and patients with gastroesophageal reflux.
Tzovaras G; Tsiaoussis J; Athanasakis E; Zoras O; Xynos E; Chrysos E
Scand J Gastroenterol; 2004 Jun; 39(6):521-6. PubMed ID: 15223674
[TBL] [Abstract][Full Text] [Related]
20. Upper esophageal sphincter and pharyngoesophageal motor function in infants with and without gastroesophageal reflux.
Sondheimer JM
Gastroenterology; 1983 Aug; 85(2):301-5. PubMed ID: 6862154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
